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Digital X-ray radiogrammetry better identifies
osteoarthritis patients with a low bone mineral
density than quantitative ultrasound
Abstract This study assessed the
ability of quantitative ultrasound
(QUS) and digital X-ray
radiogrammetry (DXR) to identify
osteopenia and osteoporosis in
patients with knee osteoarthritis
(OA). One hundred and sixty-
one patients with painful knee
OA (81 men, 80 women; age
62.6±9.2 years, range 40–82 years)
were included in this cross-sec-
tional study and underwent dual-
energy X-ray absorptiometry
(DXA) of both hips and the lum-
bar spine, QUS of the phalanges
and calcanei of both hands and
heels, and DXR using radiographs
of both hands. Unpaired t-test,
Mann-Whitney U test, ROC anal-
ysis and Spearman’s rank correla-
tion were used for comparisons
and correlation of methods. Using
DXA as the reference standard, we
defined a low bone mineral den-
sity (BMD) as a T-score ≤−1.0 at
the lumbar spine or proximal
femur. In contrast to phalangeal or
calcaneal QUS, DXR was able to
discriminate patients with a low
BMD at the lumbar spine
(p<0.0001) or hips (p<0.0001).
ROC analysis showed that DXR
had an acceptable predictive power
in identifying OA patients a low
hip BMD (sensitivity 70%, speci-
ficity 71%). Therefore, DXR used
as a screening tool could help in
identifying patients with knee OA
for DXA.
Keywords Bone mineral density .
Osteoarthritis . Quantitative
ultrasound . Dual energy x-ray
absorptiometry . Digital x-ray
radiogrammetry
Introduction
Dual-energy X-ray absorptiometry (DXA), quantitative
ultrasound (QUS) as measured in the phalanges and
calcanei, and digital X-ray radiogrammetry (DXR) of the
metacarpals are currently available to assess mineral
content and structural properties of bone tissue. DXA is
the standard tool to assess patients at risk of osteoporosis
and fracture, such as postmenopausal women [1–3].
However, DXA is not an optimal tool for population
screening because of limited availability and relatively
high costs. Therefore, new techniques with peripheral
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measurement sites to select high-risk individuals, who are
more likely to benefit from bone mineral density (BMD)
measurements by DXA, are under evaluation.
Previous studies have shown that QUS at the calcaneus
can predict hip fracture risk in elderly women over 65 years
of age and that there is a good relationship between
calcaneal broadband ultrasound attenuation (BUA) and
incident vertebral fracture and between amplitude-depen-
dent speed of sound (AD-SOS) as measured at the finger
phalanges and non-vertebral fractures [3–9]. Furthermore,
it has been shown that DXR, as measured at the
metacarpals, is able to predict fracture risk at the wrist,
spine, and hip in elderly women with a similar exactness as
lumbar spine BMD measurements [10]. Recently, many
studies have revealed the use of DXR in clinical practice,
particularly with respect to rheumatoid arthritis, in the field
of paediatrics and for prediction of fracture risk in
osteoporosis [11–15].
However, most studies focused on patient populations
with a high prevalence of osteoporosis. In contrast, a lower
incidence for osteoporosis has been observed in patients
with osteoarthritis (OA) and there is an inverse association
between the incidence of osteoporosis and OA [16].
Nevertheless, the risk of fracture is not reduced in elderly
women with knee OA [17, 18]. Furthermore, screening
elderly patients for the presence of osteoporosis will likely
include OA patients as well, as OA is the most common
form of arthritis and a common problem in the elderly.
The aim of this study was to evaluate the usability of
QUS and DXR measurements for screening purposes in
patients with OA of the knee, i.e., patients with a low
prevalence of osteoporosis. In this study we assessed if
QUS and DXR are able to identify patients with a low
BMD corresponding to a T-score ≤−1.0 as determined with
DXA of the proximal femur and lumbar spine.
Materials and methods
Patients participating in a 2-year randomised double-blind
placebo controlled clinical trial designed to assess the
potential structure modifying effects of oral chondroitin
sulphate treatment were enrolled in this evaluation. Recent
meta-analyses found that treatment with chondroitin
sulphate possibly reduces pain and improves function in
patients with knee OA [19, 20]. Volunteers participating in
this original clinical trial were asked to perform additional
bone measurements with DXA, DXR, and QUS. The
protocol of this study was approved by the local ethics
committee and all patients gave their informed consent for
participation. The results of the original clinical trial have
been reported elsewhere [21].
Patients and design of the original clinical study
Between March 1996 and May 1999, a total of 300 patients
of both gender were recruited by the Department of
Rheumatology and Institute of Physical Medicine of the
University Hospital Zurich through advertisements in the
local newspapers and posters placed at various locations at
the University of Zurich. All patients recruited had both
radiological and clinical signs of knee OA according to
ACR criteria [22]. Patients with a grade 1, 2 and 3
according to the Kellgren and Lawrence scoring system
were eligible for study entry [23]. In the scoring system
described by Kellgren and Lawrence, a grade 0 indicates a
definitive absence of radiological changes of OA (on
conventional X-ray images). Such changes include the
formation of osteophytes on the joint margins, the presence
of periarticular ossicles (mainly seen at the distal and
proximal interphalangeal joints), the narrowing of joint
cartilage associated with sclerosis of subchondral bone,
small cystic areas with sclerotic walls usually situated in
the subchondral bone, and an altered shape of the bone
ends (particularly in the head of the femur) [23]. A grade 1
indicates minimal or doubtful changes and grade 2–4
indicate changes which are definitely present with increas-
ing severity.
Exclusion criteria were patients younger than 40 or older
than 85 years, pregnancy or lactation, initial radiological
signs of severe OA (Kellgren and Lawrence radiological
score 4), chondrocalcinosis, secondary OA after trauma
and patients after rupture of the anterior cruciate ligament,
signs of skeletal hyperostosis, rheumatoid arthritis or
psoriasis, arthropathy due to metabolic diseases, Paget’s
disease, previous surgical intervention less than 6 months
before study onset or a planned surgery within the next two
years. Furthermore, patients with known hypersensitivity
to chondroitin sulphate, asthma, severe diseases of the liver
or the kidneys or a malignant disease, and the use of any
medication that could affect bone metabolism, such as
steroids, or a known abuse of pharmaceuticals were
excluded.
There were no differences between the 161 patients
volunteering for this evaluation and the 300 knee OA
patients of the original clinical trial regarding body weight,
height, body mass index (BMI), i.e., body weight in kg ÷
(height in m)2, age, gender distribution, and clinical and
radiological signs of OA. The details regarding medication
and follow-up examinations for this 2-year randomised
double-blind placebo controlled clinical trial have been
previously described [21].
For this study, all DXA, QUS, and DXR measurements
were acquired on the same day at study inclusion of the
patient. The radiographs of both hands used for DXR
measurement were also taken on the day of study
inclusion.
966
DXA measurements
The DXA measurements were performed on the supine
patient at the following sites: lumbar spine (L2–L4) and
both hips with a Hologic QDR 4500 A and C device
(Hologic Inc., Waltham, MA). The lumbar spine measure-
ment was taken exclusively from dorsal projection. At the
lumbar spine regions of interest (ROI) in the vertebral body
L2–L4 and in the hip regions of interest in the proximal
femur including a total ROI, Ward’s triangle, femoral neck,
and trochanter were evaluated. For this evaluation we used
the total hip BMD value, since this is the preferred
measurement for monitoring patients. Prior to the study, the
DXA devices were cross-calibrated using a spine phantom
and daily quality controls using the same phantom were
performed during the whole study period, according to the
recommendations of the manufacturer. A 1.5% variability
from the mean value was considered a tolerable variation of
the DXAmeasurements between the two DXA devices and
0.5% variability for the longitudinal quality control of each
individual device. In an own evaluation, the short-term
precision (CV%) of the mean BMD measurement of L2–
L4 with repositioning of the patient as done in 10
postmenopausal women was 1.2%.
All measurements and quality control were done by the
same two experienced technicians (experience of 7 and
10 years) during the whole study period.
BMD was given as absolute values in g/cm2, and as Z
and, T-score values. The Z-score corresponds to the
number of standard deviations from the mean value that
was defined by the range of BMD of an ethnically
comparable age and gender-matched reference population.
The T-score corresponds to the number of standard
deviations from the mean of a gender-matched reference
population of young adults defined as the Peak Bone Mass,
as provided by the manufacturer. In agreement with the
International Society for Clinical Densitometry (ISCD)
guidelines, osteopenia or osteoporosis were defined
according to the lowest measured value in either spine or
hip. In this study we used the total values of the L2–4
measurement at the spine and the value of the total hip
region. Osteopenia, as defined by the WHO classification,
corresponds to a T-score value between −1.0 and −2.5.
Osteoporosis was defined a T-score value of −2.5 and
lower.
DXR measurements
DXR was performed using a Sectra Pronosco X-posure
system (Version 2.0; Sectra Pronosco Inc., Vedbaek,
Denmark). With this device conventional radiographs of
the hands can be digitised and regions of interest at the
second, third and fourth metacarpal bone are automatically
drawn to measure the cortical bone volume based on
volumetric equations from a cylindrical bone model [24].
The bone mineral content and density can be calculated
from this measurement (metacarpal BMD) [25]. In addi-
tion, the system provides a porosity index analysed from
the intensity profile of the metacarpal bones and yielding
information on the presence of lacunar holes within the
cortical bone. At the time of planning this study the role of
the metacarpal index, a parameter which is automatically
calculated by the DXR system, was less clear and,
therefore, not considered for this evaluation. Radiogram-
metry using this device has been shown to have a good
correlation with forearm BMD, as measured with DXA,
and the ability to predict fracture risk [26, 10]. Further-
more, a high short-term precision (CV%) with a coefficient
of variation of between 0.4% and 0.65% have been
reported [26, 27]. In an own evaluation, the short-term
precision with repositioning of the same single hand
radiograph of 10 postmenopausal women was 0.25%.
For this study both hands of a patient were x-rayed and
high resolution radiographs were exposed with the digital
information. The hand radiographs were then scanned
using a UMAX PowerLook 110 scanner which has an
optical resolution of 1200×2400 dpi (height × width, dots
per inch). All measurements of hand radiographs were
performed by a single scientific collaborator (N.Z.). The
mean values of the metacarpals of the left and right hands
were used for the comparisons with other methods and the
parameters BMD, porosity and the T-score were analysed.
QUS measurements
The QUS measurements of both heels were acquired on an
Achilles+ device, which uses a water-bath at 37° as a
coupling medium (GE Lunar, Madison, WI, USA). The
Achilles+ generates a band of frequencies from 200 to
600 kHz. The device measures the speed of sound (SOS)
expressed in m/s and the BUA expressed in dB/MHz. In
addition, the Achilles+ system automatically calculates the
stiffness index (SI) of the heel bone using the following
formula: SI=(0.67×BUA)+(0.28×SOS)−420. SI provides
T-scores that can be compared with axial BMD measure-
ments and is considered to be able to identify patients with
osteoporotic fractures better than BUA or SOS [28].
The mean values of the left and right heel were used for
comparison with other methods and the parameters SI,
SOS, BUA and the T-score were analysed. In a recent
phantom study, the short-term precision of this device was
comparable to that of DXAwith a CV% of approximately
0.5% for the BUA parameter [29]. In the same study, the
CV% of SOS was approximately 0.3% and 1.9% for SI
[29]. In an own evaluation, the short-term precision with
repositioning the heel as measured in 10 postmenopausal
women was 0.2% for the SOS and 0.5% for the BUA
measurements.
QUS was also measured at the distal metaphysis of the
proximal phalanges of fingers II, III, IVand Von each hand
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using the DBM Sonic 1200 device (IGEA, Capri, Italy).
The transducers are positioned on the lateral surfaces of the
finger using gel as coupling material. This device generates
an ultrasound signal with a frequency of 1.25 MHz and
measures the SOS when the signal reaches minimal
amplitude of 2 mV (i.e., AD-SOS) and is expressed as
m/s. Furthermore, the pattern of the signal received is
analysed and information such as the relative peak
amplitude, peak regression and trend of SOS in the four
phalanges are combined to provide the ‘ultrasound bone
profile score’ (UBPS) as described by Wüster et al. [30].
The mean values of the phalanges of the left and right hand
were used for the comparisons with other methods and the
parameters SOS and UBPS were analysed. The short-term
precision as described by the CV% has been reported to be
0.58% for AD-SOS and 0.59% for UBPS [31]. In an own
evaluation, the short-term precision with repositioning of
the device on the same phalanges as measured in 10
postmenopausal women was 1.9% for AD-SOS and 1.4%
for UBPS. All measurements and quality control for both
devices were done by the same two experienced techni-
cians (experience of 7 and 6 years) during the whole study
period.
Statistics
The mean value and standard deviation for normally
distributed values, or in case of non-normal distribution,
the median value and range for the measured parameters
are given. Confidence intervals are given at the 95% level.
Unpaired t-test was used to test for differences between
the patients for normally distributed parameters. The
Mann-Whitney U test was used for data without normal
distribution. The results of DXA, QUS, and DXR
measurements were further compared for obese (BMI of
≥30 kg/m2) and non-obese patients using the Mann-
Whitney U test with a Bonferroni correction for multiple
measurements. The mean DXA, DXR or QUS values as
obtained from the left and right hand, hip, or heel
respectively, were used for correlation of the results of
the different methods using Spearman’s rank correlation.
Furthermore, receiver-operating characteristics were
calculated to assess the predictive power of the different
screening methods. The areas under the curve were
calculated with the 95% confidence interval.
Results
Patients and results of DXA
All patients participating in the original trial were asked to
undergo additional DXA, DXR and QUS measurements.
One hundred sixty-one out of the 300 initially included
knee OA patients volunteered for at least one additional
measurement. The patient characteristics are listed in
Table 1. Only 25 out of the 161 patients had a BMI of
less than 25 kg/m2 and 42 patients were obese, i.e., they
had a BMI of ≥30 kg/m2 (19 male, 23 female; BMI
between 30.0–46.9 kg/m2). Ninety-four patients were
overweight with a BMI between 25.1 and 29.9 kg/m2.
There were 119 non-obese patients (61 male, 58 female;
BMI between 17.7 and 29.9 kg/m2).
The results of DXA measurements are listed in Table 2.
DXA measurements revealed a decreased BMD (T-score
value −1 or lower) at the lumbar spine or hip in 84 patients
(52% of all patients; 72 patients in the lumbar spine and 36
patients in at least one hip). Osteoporosis was found in 21
patients (13% of all patients; 19 in the lumbar spine and 4
in the hip).
Mann-Whitney U test revealed a difference of lumbar
spine BMD (1.086±0.151 vs. 0.998±0.157 g/cm2) and
mean hip BMD (1.046±0.127 vs. 0.939±0.142 g/cm2)
between the 42 obese and the 119 non-obese patients.
The obese patients had significantly higher total lumbar
spine BMD (p=0.004, significance level p=0.007 after
Bonferroni correction) and higher mean hip BMD
(p=0.0001) than the non-obese patients.
Results of DXR measurements
Results of DXR measurements were available in 154
patients (76 male, 78 female; Table 3). The DXR
parameters BMD and porosity showed an excellent
correlation between the metacarpals of the left and right
hand as tested with Spearman’s rank correlation
(p<0.0001 for both parameters). There was no significant
difference between the left and right hand metacarpal
Table 1 Patient characteristics
Men (n=81)
(mean±SD;
range)
Women (n=80)
(mean±SD;
range)
Age years 62.6±9.4 62.2±9.1
40–82 41–79
Age, postmenopausal
women (n=72)
years 64.0±7.6
48–79
Age, pre-menopausal
women (n=8)
years 46.1±4.3
41–54
Body size cm 174.8±6.3 162.1±6.5
160–196 147–178
Body weight kg 84.2±12.5 73.5±14.9
62–119 45–115
Body mass index kg/m2 27.5±3.7 28.0±5.8
20.5–39.8 17.7–46.9
Characteristics of 161 volunteer patients participating in the placebo
controlled double-blind study undergoing screening with DXA,
DXR, and QUS. 90% of the women were postmenopausal.
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porosity (paired t-test, p=0.11; 95% CI for mean
difference −0.4–+0.04).
Mann-Whitney U test revealed a significant difference
for the BMD parameter, but not the porosity, between
patients with a normal and those with a low BMD at the
vertebral spine or hip (Table 3).
Mann-WhitneyU test revealed no significant difference for
the BMD parameter (0.587±0.080 vs. 0.602±0.078 g/cm2;
p=0.28) and the porosity (4.774± 0.974 vs. 4.828±0.0915%;
p=0.78) between 40 obese and 114 non-obese patients.
Results of QUS measurements
Results of QUS of the phalanges of both the left and right
hand were available in 97 patients (48 male, 49 female;
Table 4), and QUS of the left and right heel in 95 patients
(47 male, 48 female; Table 4). QUS parameters showed an
excellent correlation between the left and right side for
phalangeal SOS (p<0.0001), UBPS (p<0.0001), and cal-
caneal stiffness (p<0.0001) as tested with Spearman’s rank
correlation. There were no significant differences for the
QUS parameters as measured at the phalanges and calcanei
between patients with a normal and those with a low BMD
at the vertebral spine or hip.
Mann-Whitney U test revealed no significant differ-
ence for the phalangeal ultrasound parameter SOS
(2990.9±121.6 vs. 2990.6±161.2 m/s; p=0.80) and
UBPS (98.6±43.6 vs. 87.5±38.9; p=0.27) between 28
obese and 69 non-obese patients. Furthermore, Mann–
Whitney U test revealed no significant difference for
calcaneal stiffness (128.6±21.6 vs. 136.7±24.7; p=0.19)
between 27 obese and 68 non-obese patients.
Correlation of DXR and QUS with DXA
The results of Spearman’s rank correlation of the different
methods are listed in Table 5. There was a significant
correlation between the lumbar spine BMD and the mean
metacarpal DXR BMD (p<0.0001) and mean metacarpal
porosity value (p=0.007) of left and right hand DXR
(Table 5). Mann–Whitney U test revealed a significant
difference of the mean metacarpal DXR BMD (p=0.01) but
not of the mean metacarpal porosity value (p=0.66) of both
hands between the groups with normal and low T-scores at
the lumbar spine. Additionally, there was a significant
correlation between the mean BMD value of left and right
hip and the mean value of left and right hand metacarpal
DXR BMD (p<0.0001), but not for the porosity index
(p=0.11; Table 5). The comparison of DXR BMD values in
patients with a normal versus a low T-score in at least one
of both hips revealed a significant difference (p<0.0001).
This was not the case for the mean metacarpal porosity
index (p=0.32). Only the DXR BMD parameter was able to
discriminate patients with low BMD T-score at the spine or
hips from patients with normal BMD. However, the mean
metacarpal DXR BMD value was more suitable to identify
female patients (p=0.008) than male patients (p=0.28) with
a low BMD at the lumbar spine. In contrast, the mean
Table 3 DXR measurements
Patients n=154 Mean± SD Range Correlation
between left
and right hand
Mean±SD
in patients
with normal
BMD**
Mean±SD
in patients
with a low
BMD**
Mann–Whitney
U p-value
*Mean metacarpal BMD g/cm2 0.591± 0.079 0.390–0.750 0.95 0.612±0.073 0.573±0.081 p=0.002
*Mean metacarpal porosity % 4.79± 0.95 2.3–6.8 0.41 4.83±0.89 4.75±1.01 p=0.74
* The arithmetic mean of the metacarpal measurements of the left and right hand is given.
** Patients with a low BMD are those with a T-score value of −1.0 and less, as measured at the lumbar spine or the hip. Patients with normal
BMD have T-score values above −1.0.
Table 2 DXA measurements
* The left hip was measured in
157 patients; the right hip was
measured in 155 patients
n=161 patients Mean±SD Range
Lumbar spine total BMD g/cm2 1.021±0.159 0.580–1.450
Lumbar spine T-score Median −0.7 −4.5–+3.3
Lumbar spine Z-score Median +0.5 −3.4–+4.0
*Left hip total BMD g/cm2 0.971±0.146 0.530–1.320
Left hip T-score Median −0.2 −3.4–+1.9
Left hip Z-score Median +0.6 −2.6–+3.3
*Right hip total BMD g/cm2 0.961±0.150 0.460–0.135
Right hip T-score Median −0.3 −4.0–+2.1
Right hip Z-score Median +0.6 −3.3–+2.9
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metacarpal DXR BMD value was able to identify female
and male patients with a low BMD at the hip (female:
p<0.0001; male: p=0.008).
No significant difference was found for the mean
phalangeal QUS value between patients with lumbar
spine osteopenia/ osteoporosis and patients with normal
spine BMD (p=0.86). The evaluation of phalangeal QUS
revealed that this method was not able to identify patients
with a low BMD at the lumbar spine or at the hip level,
independent of gender (male: p=0.91 for SOS and p=0.88
for UBPS for hip BMD; p=0.96 for SOS and p=0.73 for
UBPS for lumbar spine BMD; female: p=0.92 for SOS and
p=0.94 for UBPS for hip BMD, p=0.77 for SOS and
p=0.95 for UBPS for lumbar spine BMD).
The analysis of QUS of the heels using the Mann–
Whitney U test also revealed no significant difference
between the mean stiffness value of the patients with a low
and a normal T-score at the lumbar spine (p=0.62) or hips
(p=0.61). The mean stiffness value of heel QUS measure-
ments was not able to identify those patients with a low
BMD at the lumbar spine and hips in the male patients
(p=0.46 for hip BMD, p=0.43 for lumbar spine BMD) and
in the female patients (p=0.22 for hip BMD, p=0.91 for
lumbar spine BMD).
Table 4 QUS measurements
Mean± SD Range Correlation
between
left and right
side
Mean±SD
in patients
with normal
BMD**
Mean±SD
in patients
with a low
BMD**
Mann–Whitney
U p-value
QUS hands (n=97)
*Mean phalangeal SOS m/s 1992.6± 100.5 1713.5–2253.0 0.91 1990.9±109.3 1994.3±92.6 p=0.82
*Mean phalangeal UBPS 60.5± 26.6 5.5–100.0 0.89 60.9±28.5 60.1±25.0 p=0.94
QUS heels (n=95)
*Mean calcaneal stiffness 89.5± 15.7 52–135 0.90 90.3±15.0 88.6±16.2 p=0.65
* The arithmetic mean of phalangeal measurements of both hands and calcaneal measurements of both heels are given.
** Patients with a low BMD are those with a T-score value of −1.0 and less, as measured at the lumbar spine or the hip. Patients with normal
BMD have T-score values above −1.0.
Table 5 Spearman’s rank correlation of methods
Mean metacarpal
DXR, BMD
correlation,
p-value
Mean metacarpal
DXR, porosity
correlation,
p-value
Mean phalangeal
QUS, SOS
correlation,
p-value
Mean phalangeal
QUS, UBPS
correlation,
p-value
Mean calcaneal
QUS, stiffness
correlation,
p-value
Lumbar spine
BMD correlation,
p-value
Mean meta-
carpal DXR,
porosity
0.22, 0.007 *
Mean phalan-
geal QUS,
SOS
−0.02, 0.85 0.11, 0.28
Mean phalan-
geal QUS,
UBPS
0.02, 0.85 0.12, 0.25 −0.82, <0.0001 *
Mean calca-
neal QUS,
stiffness
0.01, 0.97 0.04, 0.69 0.52, <0.0001 * 0.54, <0.0001 *
Lumbar spine
BMD
0.38, <0.0001 ** 0.10, 0.24 −0.04, 0.72 −0.01, 0.93 0.03, 0.97
Mean hip
BMD
0.66, <0.0001 ** 0.13, 0.11 0.01, 0.96 0.09, 0.42 0.08, 0.47 0.65, <0.0001 *
Spearman’s rank correlations and p-values are given for the measurements.
* A significant relationship was found for the ultrasound measurements at the different sites and for the measurements of BMD and porosity
at the metacarpals and BMD measurements at the hips and lumbar spine, respectively.
** The correlation of DXR based metacarpal BMD and DXA based BMD of the hip or spine is highly significant.
970
Performance of the measurement methods
The ability of DXR and QUS measurements to predict a
low BMD at the vertebral spine or hip was additionally
evaluated using the T-score values of the DXR and QUS
measurements. The sensitivity and specificity for the mean
DXR T-score of ≤−1.0 as measured with DXR of both
hands to identify a hip BMD of ≤−1.0 was 70% (male
60%, female 74%) and 71% (male77%, female 65%). For
the identification of a low BMD at the lumbar spine the
sensitivity and specificity was 43% and 68%, only, for
male and female patients together. In contrast, the
sensitivity and specificity for the mean T-score of ≤−1.0
as measured with QUS of both heels to identify a hip BMD
of ≤−1.0 was 47% and 55% calculated for both genders
together. For the identification of a low BMD at the lumbar
spine the sensitivity and specificity was 45% and 56% for
male and female patients together. The sensitivity and
specificity for the mean T-score of ≤−1.0 as measured with
QUS of both hands to identify a hip BMD of ≤−1.0 was
70% and 26% calculated for both genders together. For the
identification of a low BMD at the lumbar spine the
sensitivity and specificity was 79% and 34%.
In combination with T-score values of ≤−1.0 of the
DXR and QUS devices to identify patients with a low
BMD as defined by DXA, the DXR method had the best
predictive power to indicate osteopenia or osteoporosis at
the hip in both male and female patients. The area under
the curve was 0.82 (95% CI: 0.74–0.90) for all patients. In
Fig. 1 the ROC curves of male and female patients are
shown. The area under the curve for female patients was
0.83 (95% CI: 0.74–0.93) and for male patients 0.77 (95%
CI: 0.60–0.93). However, DXR was less suitable for
predicting a low BMD at the vertebral column with an area
under the curve of 0.64 (95% CI: 0.55–0.73) for male and
female patients together. In contrast, the predictive power
of QUS measured at the heels was insufficient to identify
patients with a low BMD at a hip with an area under the
curve of 0.46 (95% CI: 0.31–0.61), as well as patients with
a lumbar spine T-score of ≤−1.0 with an area under the
curve of 0.51 (95% CI: 0.38–0.63). The predictive power
of QUS measured at the phalanges was also insufficient to
identify patients with a low BMD at a hip with an area
under the curve of 0.53 (95% CI: 0.38–0.67), as well as
patients with a T-score of ≤−1.0 at the lumbar spine with
an area under the curve of 0.44 (95% CI: 0.33–0.56), as
calculated for male and female patients together.
Discussion
In this study, DXR of the metacarpals was able to identify
male and female patients with a low hip BMD correspond-
ing to a T-score ≤−1.0 as measured with DXA. In contrast,
neither phalangeal QUS of both hands nor calcanei was
able to identify OA patients with osteopenia or osteopo-
rosis at the lumbar spine or hips. The use of QUS and DXR
for screening purposes has already been evaluated by
several groups [32–35]. According to the official positions
of the ISCD, DXA measurements are useful in women
65 years of age and older, in men 70 years of age and older,
and in patients with an underlying disease, condition or
medication associated with low bone mass or bone loss
[36]. Therefore, DXA cannot be recommended as a
screening tool in patients such as those examined in our
Fig. 1 a and b ROC curve of female (1A) and male (1B) patients
for the ability of a low mean DXR T-score (≤−1.0) to identify
osteopenia or osteoporosis at a hip. The area under the curve was
0.83 for female and 0.77 for male patients
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study. Since OA is common in the elderly and is known to
have an influence on BMD, the possible use of new
screening techniques has also to be evaluated in OA
patients [16]. Screening of patients with DXR could be a
simple and accessible method to identify patients in high-
risk groups for osteoporosis. The possibility to identify
patients who are likely to have a low T-score at the lumbar
spine and hips is interesting in regard to future clinical
application. In our male and female knee OA patients, the
DXR technique was able to identify patients with a low hip
BMD with an acceptable sensitivity and specificity,
although the prevalence of osteopenia and osteoporosis is
rather low in OA patients. On the other hand, the test
performance was insufficient for the identification of a low
BMD at the lumbar spine and only the DXR BMD
parameter was able to discriminate these patients, while the
porosity index was not. Because it is common to acquire
hand radiographs in patients with OA to assess involve-
ment of finger joints, DXR may become a cost efficient
screening method in OA patients.
A limitation of our data is that there were not enough
patients for a subgroup comparison of patients with
osteopenia and osteoporosis. 52% of the patients had a
T-score indicating osteopenia at the lumbar spine or hip and
13% of all patients had osteoporosis. We pooled these
patients and compared the patients with a normal T-score
with those having a low T-score of ≤−1.0 corresponding to
osteopenia or osteoporosis. Furthermore, the number of
subjects undergoing the three different techniques greatly
varied and, therefore, an analysis of further subgroups such
as male and female patients with osteopenia or osteopo-
rosis would have been less meaningful.
The results of this study are in line with previous
observations suggesting that osteoporosis is a rather
uncommon finding in OA patients [18]. The DXA
Z-score of our study patients, i.e., the comparison to age
and gender matched controls, indicated a tendency to a
relatively higher BMD at the lumbar spine and both hips.
The slightly higher Z-score probably reflects the effect of
the patients’ weight on structural bone properties and not a
direct influence of OA on the bone structure. Many patients
in this study had a high BMI and it is well known that OA
patients are often obese. The separate analysis of patients
with a BMI of ≥30 kg/m2 revealed that the total lumbar and
mean hip BMD as measured with DXA was significantly
higher in obese patients than in patients with a BMI of less
than 30 kg/m2 (normal weight and overweight patients). In
contrast, there was no difference for the DXR parameters
metacarpal BMD and porosity between obese and non-
obese patients. Additionally, there was no difference for
phalangeal SOS and UBPS measurements as well as for
calcaneal stiffness for these two patient subgroups. This
finding is explained by an influence of obesity on the
technical performance of DXA BMD measurement,
leading to overestimation of BMD values. It has previously
been shown that in contrast to the DXA method, there is no
influence of body size and weight on the results of DXR-
BMD measurements [36].
In accordance to the official positions of the Interna-
tional Society for Clinical Densitometry, we used the femur
BMD value with the lower total femur BMD to define the
presence of osteopenia or osteoporosis at the hip level for
the statistical evaluation [37]. In contrast, we used the mean
values of the DXR and QUS measurements, obtained at
both hands and heels, and not the lowest value of just one
side. Often the measurements are only acquired on the non-
dominant hand or heel. In a previous work, it has been
suggested to measure both calcanei and to use the lower of
both measured values in routine clinical practice [38].
Furthermore, it has been recommended to acquire ultra-
sound measurements at other sites, such as the forearm on
both sides [39]. In our study, we used the mean values of
QUS and DXR measurements of both hands and the mean
values for the calcaneal QUS as it may be difficult to
choose the non-dominant hand or leg in patients with knee
OA. The use of walking sticks, altered loading and weight-
bearing may influence bone properties at the so-called non-
dominant side. We decided to use the mean values in order
to avoid overestimation of the incidence of pathologically
low values.
To further evaluate the performance of the DXR device
and QUS devices, we used the T-score values. For these
devices the use of T-score values has not been validated for
their clinical significance. In contrast, the T-score values
used for BMD results, as based on DXA, express important
clinical information in terms of increased fracture risk. It
might be argued that a T-score value, when used for DXR,
is meaningless, as its clinical role has not been defined.
Therefore, we suggest performing studies to appraise the
use of T-score values in DXR and QUS based techniques
and to better define the clinically relevant thresholds.
In this cross-sectional study we did not assess the
influence of OA in our patients on fracture incidence. We
assessed a group of rather young patients with a mean age
of approximately 63 years and, therefore, with a low
probability of fracture. It is well known that calcaneal QUS
is almost as predictive for fracture as hip DXA, but at this
stage, it is not clear if DXR or QUS of the phalanges are
reliable screening tools to predict fracture risk. Therefore,
studies should further assess the clinical role of hand
measurements using DXR and QUS and evaluate the
relationship between knee OA and fracture risk.
The results of this study suggest that DXR of hand
radiographs, which are often acquired in patients with knee
OA, have the potential to identify male and female patients
with a low hip BMD corresponding to a T-score ≤−1.0 as
measured by DXA. In contrast, QUS measurements of the
heels and fingers acquired in this population, with a low
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prevalence of osteopenia or osteoporosis, were not suitable
to identify patients who possibly should undergo DXA.
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